May 24, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ecopetrol S.A. (“Ecopetrol” or “the Company”) (NYSE: EC). Investors who purchased Ecopetrol securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Ecopetrol has violated federal… read more
May 22, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Volkswagen AG (“Volkswagen” or “the Company”) (OTCMKTS: VWAGY). Investors who purchased Volkswagen securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Volkswagen has violated federal… read more
May 22, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bayerische Motoren Werke AG (“BMW” or “the Company”) (OTCMKTS: BMWYY). Investors who purchased BMW securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether BMW has… read more
May 17, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Squarespace, Inc. (“Squarespace” or “the Company”) (NYSE: SQSP). Investors who purchased Squarespace securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Squarespace and certain of its… read more
May 10, 2024 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against MacroGenics, Inc. (“MacroGenics” or “the Company”) (NASDAQ: MGNX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for… read more
May 10, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Masimo Corporation (“Masimo” or “the Company”) (NASDAQ: MASI). Investors who purchased Masimo securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Masimo has violated federal… read more
May 6, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arhaus, Inc. (“Arhaus” or “the Company”) (NASDAQ: ARHS). Investors who purchased Arhaus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Arhaus has violated federal… read more
May 3, 2024 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Fastly, Inc. (“Fastly” or “the Company”) (NYSE: FSLY) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for… read more
May 3, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Remitly Global, Inc. (“Remitly” or “the Company”) (NASDAQ: RELY). Investors who purchased Remitly securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Remitly has violated… read more
May 2, 2024 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against CVS Health Corporation (“CVS” or “the Company”) (NYSE: CVS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants… read more
May 1, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medifast, Inc. (“Medifast” or “the Company”) (NYSE: MED). Investors who purchased Medifast securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Medifast has violated federal… read more
May 1, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Comtech Telecommunications Corp. (“Comtech” or “the Company”) (NASDAQ: CMTL). Investors who purchased Comtech securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Comtech has violated… read more
May 1, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cidara Therapeutics, Inc. (“Cidara” or “the Company”) (NASDAQ: CDTX). Investors who purchased Cidara securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cidara has violated… read more
May 1, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Deutsche Bank Aktiengesellschaft (“Deutsche Bank” or “the Company”) (NYSE: DB). Investors who purchased Deutsche Bank securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Deutsche… read more
April 22, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Primerica, Inc. (“Primerica” or “the Company”) (NYSE: PRI). Investors who purchased Primerica securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Primerica has violated federal… read more
April 22, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zoetis Inc. (“Zoetis” or “the Company”) (NYSE: ZTS). Investors who purchased Zoetis securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Zoetis has violated federal… read more
April 18, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Catalent, Inc. (“Catalent” or “the Company”) (NYSE: CTLT) in regards to the sale of Catalent to Novo Holdings for $63.50 per share in cash is fair to Catalent shareholders. Investors who… read more
April 16, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Live Nation Entertainment, Inc. (“Live Nation” or “the Company”) (NYSE: LYV). Investors who purchased Live Nation securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
April 15, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Snap One Holdings Corp. (NASDQ : SNPO) (“Snap One” or “the Company”). Investors who purchased Snap One securities are encouraged to obtain additional information and assist the investigation. Investigation Details: Under… read more
April 12, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Morgan Stanley (“Morgan Stanley” or “the Company”) (NYSE: MS). Investors who purchased Morgan Stanley securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Morgan Stanley… read more
April 4, 2024 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Doximity, Inc. (“Doximity” or “the Company”) (NYSE: DOCS) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for… read more
April 3, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tyra Biosciences Inc (“Tyra” or “the Company”) (NASDAQ: TYRA). Investors who purchased Tyra securities are encouraged to obtain additional information and assist the investigation. Investigation Details: The investigation concerns whether Tyra… read more
March 28, 2024 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Li Auto Inc. (“Li Auto” or “the Company”) (NASDAQ: LI) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against… read more
March 28, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DraftKings Inc. (“DraftKings” or “the Company”) (NASDAQ: DKNG). Investors who purchased DraftKings securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether DraftKings has violated federal… read more
March 26, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Franklin Wireless Corp. (“Franklin Wireless” or “the Company”) (NASDAQ: FKWL). Investors who purchased Franklin Wireless securities prior to September 17, 2020, and continue to hold to the present, are encouraged to… read more
March 26, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Pharmaceuticals Inc. (“Acadia ” or “the Company”) (NASDAQ: ACAD). Investors who purchased Acadia securities prior to September 9, 2019, and continue to hold to the present, are encouraged to obtain… read more
March 20, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Expensify, Inc. (“Expensify” or “the Company”) (NASDAQ: EXFY). Investors who purchased Expensify securities prior to November 11, 2021, and continue to hold to the present, are encouraged to obtain additional information… read more
March 19, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating whether the sale of Everbridge, Inc. (NASDAQ: EVBG) to Thoma Bravo for $35.00 per share in cash is fair to Everbridge shareholders. Investors who purchased Everbridge securities prior to February 2024, and continue to hold to the present,… read more
March 14, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Thoughtworks Holding, Inc. (“Thoughtworks”) (NASDAQ: TWKS) and Apax Partners LLP. Investors who purchased Thoughtworks and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm’s… read more
March 14, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Repare Therapeutics Inc. (“Repare” or “the Company”) (NASDAQ: RPTX). Investors who purchased Repare securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Repare has violated… read more